Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infection
about
Immunoregulatory functions of immune complexes in vaccine and therapyEvidence for Persistence of Ectromelia Virus in Inbred Mice, Recrudescence Following Immunosuppression and Transmission to Naïve MiceConverting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into playCell-targeting antibodies in immunity to EbolaVaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival.Type I interferon suppresses virus-specific B cell responses by modulating CD8(+) T cell differentiationAntibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.Costimulatory and Coinhibitory Receptor Pathways in Infectious DiseaseThe many faces of FcγRI: implications for therapeutic antibody function.Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.Modulating immunogenicity of factor IX by fusion to an immunoglobulin Fc domain: a study using a hemophilia B mouse model.Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection.Anti-CD20 Antibody with Multimerized Fc Domains: A Novel Strategy To Deplete B Cells and Augment Treatment of Autoimmune Disease.Irreversible splenic atrophy following chronic LCMV infection is associated with compromised immunity in mice.Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions.Inhibition of the FGL2:FcγRIIB/RIII Immunosuppressive Pathway Enhances Antiviral T cell and B Cell Responses Leading to Clearance of LCMV cl-13.Detection of Experimental and Clinical Immune Complexes by Measuring SHIP-1 Recruitment to the Inhibitory FcγRIIB.MEDI-551 Treatment Effectively Depletes B Cells and Reduces Serum Titers of Autoantibodies in Mice Transgenic for Sle1 and Human CD19.Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever
P2860
Q26738396-B9D1256B-D3AC-4D8D-B7FF-B8C20A5EAEF9Q27316583-D2B7B8D2-C2A3-45BE-BF56-6C94240F953EQ27468870-B0825BA3-6D8B-4DB7-BE61-A8D035D1704CQ28068972-F65214A4-D385-4477-8DBD-E64970D32100Q30299957-0D06F369-A432-4E10-AAE3-6FDCC04D7840Q30827049-232C1850-F40B-43B1-AAE5-3A27B5B1B2ACQ35933820-770D8948-D282-4D38-84AE-BED8A3EB2024Q36919711-C88C23F9-8308-4A79-9AD2-5F3A9E6514C6Q38615362-EF3DFA71-20DC-4090-9ABC-9E61C8DB97B9Q38615376-1FE57066-3D92-4207-8009-A75FC1B3423CQ38760836-3C59B20C-C3B4-4BBD-8241-CCA75B675D8AQ39588420-AB0766EA-8C54-4A41-A590-CB0B6B4BE426Q40180170-84AE55F5-0A3A-49DA-B34B-DEFCA21CC9C1Q40468923-A249EF52-874B-4684-A8C0-29E273AEF540Q42372842-9946D938-E414-4E1C-9E35-F7B279E95C11Q47148202-80A70CE5-E182-4CD3-B6C6-ABA403E095AAQ47552592-7F0E7BE9-191C-4A4C-B84F-CD35883B0363Q48204990-0D9C7305-646D-43DA-900A-F3141ABB4898Q53264199-6CAA917D-70BD-44EF-A3B1-FF3A40B028CDQ57476548-D93D2C57-758B-44E9-A8AE-69A12CC228BE
P2860
Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infection
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Suppression of Fcγ-receptor-me ...... ing persistent viral infection
@ast
Suppression of Fcγ-receptor-me ...... ing persistent viral infection
@en
type
label
Suppression of Fcγ-receptor-me ...... ing persistent viral infection
@ast
Suppression of Fcγ-receptor-me ...... ing persistent viral infection
@en
prefLabel
Suppression of Fcγ-receptor-me ...... ing persistent viral infection
@ast
Suppression of Fcγ-receptor-me ...... ing persistent viral infection
@en
P2093
P2860
P1433
P1476
Suppression of Fcγ-receptor-me ...... ing persistent viral infection
@en
P2093
David G Brooks
Douglas H Yamada
Heidi Elsaesser
John M Timmerman
Juan Carlos de la Torre
Sherie L Morrison
P2860
P304
P356
10.1016/J.IMMUNI.2015.01.005
P407
P577
2015-02-10T00:00:00Z